Today, we kick off Innovation Week! Chris sits down with Gary Pisano, professor at Harvard Business School, and author of over 100 scholarly articles on innovation and business management. His most recent book, Creative Construction: The DNA of Sustained Innovation is a look at how large enterprises can leverage their scale to become transformational innovators.
Chris also talks about pitching consulting services (it’s hard, and he doesn’t like it), how innovation can take a lot of forms that we don’t notice, and how one company is finally reckoning with its terrible past.
Read more of Professor Pisano’s scholarly work (referenced in the interview):
Buy a copy of Creative Construction here.
The Ten Types of Innovation can be found here.
From the NY Times: Nazis Killed her Father. Then She Fell in Love With One
More about Professor Pisano:
Gary Pisano is the Harry Figgie Professor of Business Administration at the Harvard Business School where he currently serves as Senior Associate Dean for Faculty Development (promotions and tenure). He joined the Harvard faculty in 1988 after completing a Ph.D. at the University of California Berkeley.
Over the course of his career, Pisano has explored fundamental questions about how organizations innovate, learn, compete, and grow. His research and consulting experience has spanned a broad range of industries including aerospace, automobiles, apparel, biotechnology and pharmaceuticals, entertainment, financial services, health care, restaurants, semiconductors, software, specialty chemicals, and web services.
At Harvard, Pisano has taught MBA, executive, and doctoral courses, and has mentored a number of doctoral students. He has created and currently teaches a new MBA electric course “Managing Growth” based on his current research on the drivers and impediments to organizational scaling and growth. He is also the co-creator and co-chair of a new executive program called “Driving Profitable Growth”.
In addition to his academic research and teaching, Pisano serves as an advisor to senior leaders at leading companies around the world and has been a director of both public and private company boards. He currently serves on the board of directors of Axcella Health and Celixir.